Zorbium Zorbium for Cats, 20mg/mL, 2.6-6.6 lB, CIII (C3) 10 x 0.4 mL Box and 1 more item

The University of Virginia awarded contract A207_PO-0458083 to WA Butler Company DBA Covetrus North America, LLC on July 15, 2026, with a cumulative contract value of $539.00. The contract involves the procurement and delivery of two pharmaceutical products to Mary Grachus Harp: Zorbium (zorbium for cats, 20 milligrams per milliliter, 2.6–6.6 pounds) in a quantity of one box at a unit price of $117.20, and Ethiqa XR (buprenorphine extended-release injectable suspension, 1.3 milligrams per milliliter) in a quantity of one 3-milliliter vial at a unit price of $422.45. Both products are controlled substances classified as Schedule III (C3) under federal regulations.

This contract represents a direct purchase order for pharmaceutical supplies by the University of Virginia, a state institution in Virginia. The award was made to the prime contractor Covetrus North America, LLC, a national veterinary pharmaceutical distributor. The cumulative contract value of $539.00 reflects the sum of the two line items specified for delivery. No annual value, overall contract period of performance, or recurring renewal terms are specified in the available documentation.